Escolar Documentos
Profissional Documentos
Cultura Documentos
Karlsruhe Institute of Technology (KIT), Institut fr Technische Thermodynamik und Kltetechnik, Germany
Institut fr Physikalische Chemie, Department fr Chemie, Universitt zu Kln, Germany
a r t i c l e
i n f o
Article history:
Received 7 June 2010
Received in revised form 12 August 2010
Accepted 24 August 2010
a b s t r a c t
The poor dissolution behaviour of solid drugs in biological environment leads to a low bioavailability.
However, the dissolution rate of such drugs can be enhanced dramatically by reduction of the particle size. At present, supercritical uid based particle size reduction processes are gaining in importance
in pharmaceutical technology. For the design of such particle formation processes and the determination of their best operating conditions the knowledge of phase equilibrium and solute solubility in a
supercritical uid is essential. Today, models based on equations of state, together with different mixing
rules, are most widely used to correlate and predict the solubility in supercritical uids. Therefore the
accurate knowledge of the required solute data, such as critical parameters, acentric factor, solid molar
volume, and sublimation pressure of the solutes is essential. However, the common, non-equation of
state based group-contribution methods are mostly empirical and often lead to inconsistent and unreliable results. Thus, due to the lack of information on these data, density-based models are often used
for the correlation of experimental solubility data. In this investigation, the solubility of Salicylic acid, of
S-Naproxen, of RS-Ibuprofen and of Phytosterol in CO2 is correlated by different methods: two methods
for the pressuresolubility correlation and two methods for the densitysolubility correlation. In addition, the inuence of solute data predicted by different group-contribution methods is investigated. With
the exception of S-Naproxen all systems investigated can be modelled sufcient well with a non-cubic
equation of state while a cubic equation of state gives less accurate results. In addition, it is shown that
for the solutes investigated, the equation of state based method is very sensitive to the values of the
sublimation pressure.
2010 Elsevier B.V. All rights reserved.
1. Introduction
The knowledge of phase equilibrium and solute solubility in a
SCF is essential for the design of particle formation processes and
the determination of their best operating conditions. With regard to
the PGSS process (Particle Generation from Gas Saturated Solution),
the ability of the supercritical solvent to melt the solid and to form
saturated liquid phase is of major interest. In the GAS process (Gas
Anti-Solvent) the SCF acts as an anti-solvent while in case of the
RESS process (Rapid Expansion of Supercritical Solutions) enables
the solvent free formation of submicron particles. In addition, the
properties of the produced powders such as particle size and morphology are often strongly inuenced by the underlying phase
behaviour. Until today, much work has been done on producing
submicron poor water soluble substances by RESS and dissolu-
Nomenclature
a
A
b
B
c
C
d
D
E
kij
lij
p
pc
R
S
T
Tm
TTP,2
Tc,1
vi
xi
y2
463
Table 1
Physical properties of the substances investigated.
Solid
CAS number
M (g/mol)
Tm (K)a
hfus
(kJ/mol)a
i
Salicylic acid
RS-Ibuprofen
S-Naproxen
Phytosterol
69-72-7
15687-27-1
22204-53-1
83-46-5
138.12
206.28
230.26
414.72
431.5
348.6
427.7
411.5
27.8
25.5
31.4
18.9
Cubic equations of state are often used to describe the experimental results of the solubility y2 of an organic solid in a
supercritical uid. These equations of state are empirical further
developments of the van der Waals equation of state [2]. In the
present investigation we used the original PengRobinson Equation
of State (PR-EoS) [3] to describe the solubility y2 .
p=
a(T )
RT
2
(v b)
v + 2bv b2
(1)
In Eq. (1) p is the pressure, T the temperature, v the molar volume, and R the gas constant. The PR-EoS was applied to binary
systems using the van der Waals 1-uid mixing rules:
a=
k
k
xi xj aij
aij =
ai aj (1 kij )
(2a)
i=1 j=1
b=
k
k
xi xj bij
bij =
bii + bjj
2
(1 lij )
(2b)
i=1 j=1
The parameters a and b can be calculated from the critical properties of the pure components. The binary interaction parameters
can be obtained by regression of the experimental data with the
EoS and the mixing rules (see Eqs. (2a), (2b)):
Fig. 1. Typical pT projection for an asymmetric mixture consisting of a supercritical
uid (1) and a low volatile solid (2).
a = 0.45724
R2 Tc2
(T, )
pc
(2c)
464
with
(T, )=(1+0.37464+1.542260.269922 (1
T/Tc ))
(2d)
and
b = 0.0778
RTc
.
pc
(2e)
In Eqs. (2c)(2e) is the acentric factor, and Tc and pc the critical data. This procedure requires the accurate knowledge of the
various thermophysical data, such as critical data, acentric factor,
solid molar volume, and sublimation pressure of the solutes [46].
The correlation which was used to calculate the solubility of the
solute in the supercritical solvent is shown in Eq. (3). This equation
is a result of the equifugacity condition between the solid and the
uid phase, under the assumption that the solubility of the solvent
is negligible in the solid phase.
y2 (p, T ) =
v2 (p p2,sub )
RT
(3)
with = (, T )
(4)
p
2,sub
p0
=A
B
(5)
with
Red =
1
1,c
(6)
(7)
y2 p
p2,sub (T )
(8)
Table 2
Values of the pure component parameters for the solids investigated using different group-contribution methods (numerary in brackets correspond to number of GCM).
Tb (K)
Tc (K)
571646
542673
584743
584993
738913
717891
768990
7071219
pc (MPa)
4.55.7
2.12.5
1.92.7
0.961.2
()
0.760.89
0.740.87
0.780.94
0.791.2
vi (m3 /mol)a
9.59 105
1.88 104
1.78 104
4.11 104
465
vc
Group contribution
methods
FormanThodos
Tb / Tc
Edminstermethod
Tc
Tb
Coutsikos
pc
Millercorrelation
103
10 1
(b) RS-Ibuprofen
102
10 0
100
p2,sub (Pa)
p2,sub (Pa)
101
-1
10
10-2
10-3
10 -2
[19]
Eq. (5)
[12]
[18]
[12]
-4
10
10
2,4
10 -1
2,6
2,8
3,0
3,2
-3
2,8
2,9
-1
1000/T (K )
3,0
3,1
3,2
3,3
3,4
-1
1000/T (K )
1
10
(c) S-Naproxen
p2,sub (Pa)
10
-1
10
-2
10
10-3
2,4
[11]
[12]
Eq. (5)
2,6
2,8
3,0
-1
1000/T (K )
Fig. 3. Comparison between experimental and calculated sublimation pressure data for a) Salicylic acid, b) RS-Ibuprofen, and c) S-Naproxen.
466
Table 3
Constants of Eq. (5) for the sublimation pressure data (p0 = 1 Pa) and temperature
range over which the data were determined.
Solute
B (K)
T range (K)
Salicylic acid
RS-Ibuprofen
S-Naproxen
Phytosterol
34.6
42.1
39.7
45.9
11484
14554
15431
18919
368408
296337
341397
298343
S 1 T
m
i
T
T
(9)
10 -3
-2
10
y2 (-)
y2 (-)
10 -4
-3
10
10 -5
308 K [20]
313 K [20]
318 K [20]
328 K [20]
323 K [23]
10 -6
-0,8
308 K
313 K
323 K
-4
-0,4
0,0
ln( 1/
0,4
10
0,8
-0,4
) (-)
0,4
ln( 1/
1,C
0,8
) (-)
1,C
323 K
333 K
343 K
313 K
323 K
333 K
343 K
353 K
-4
y2 (-)
10
y2 (-)
10 -4
0,0
10 -5
-0,2
-5
0,0
0,2
0,4
ln( 1/
) (-)
1,C
0,6
0,8
10
0,2
0,4
ln( 1/
0,6
) (-)
1,C
Fig. 4. Solubility versus reduced solvent density for a) CO2 /Salicylic acid [20,23], b) CO2 /RS-Ibuprofen [24], c) CO2 /S-Naproxen [6], and d) CO2 /Phytosterol [28]. The solid
lines are calculated with Eq. (6).
467
Table 4
Constants of Eq. (6) for the solubility of solids in sc-CO2 .
T (K)
Number of data
points
ARD (%)
308.15
313.15
318.15
328.15
313.15
333.15
308.15
318.15
323
11
15
12
11
12
11
8
12
7
10.520
9.982
9.799
9.186
10.099
8.678
10.351
9.491
10.002
3.980
3.462
3.553
3.619
3.949
2.630
3.914
3.206
4.531
5.9
7.0
8.1
6.0
13.0
14.8
0.9
6.9
3.3
RS-Ibuprofen [24]
308.15
313.15
318.15
15
6
8
9.125
8.806
8.112
5.944
6.330
5.523
5.2
4.5
21.9
S-Naproxen [25]
313.1
323.1
333.1
308
318
328
338
348
313.15
313
323
333
343
353
6
6
6
8
8
8
8
8
9
3
4
5
5
6
13.266
12.513
11.940
13.614
12.170
11.953
11.004
10.706
13.979
13.230
12.613
12.120
11.570
10.830
4.431
3.952
3.653
4.657
3.123
3.419
2.634
3.084
6.018
4.165
4.079
3.942
3.912
3.924
6.4
7.6
6.9
6.9
7.2
14.0
20.8
31.6
6.5
1.9
2.1
5.4
1.4
4.1
323.2
333.2
343.2
8
7
8
12.437
11.632
11.185
5.741
5.143
5.790
9.0
3.7
3.5
S-Naproxen [26]
S-Naproxen [27]
S-Naproxen [6]
Phytosterol [28]
ARD =
1
N
N
y
2,calc y2,exp
y2,exp
100.
31) MPa, no other solubility data has been reported for Phytosterol
[28].
For all investigated substances, the experimental results show
trends which are similar to those observed for other solids in the
supercritical region. In agreement with Eq. (6) and as it is illustrated in Fig. 4, relationship between the logarithmic solubility
and the reduced density shows the expected linear behaviour for
all isotherms. At constant temperature, the solubility of a solute
increases almost linear with the solvents density and therewith
solvent power. Fig. 4 also shows the pronounced temperature
effect on the solubility in the region outside the retrograde
region. In this region, the effect of the temperature on the solute
sublimation pressure overlays the effect of the solvent density,
Table 5
Constants of Eq. (7) for the solubility of solids in sc-CO2 .
Number of
isotherms
c (K)
d (K dm3 /mol)
ARD (%)
4
2
2
1
1180.3
1206.5
1457.9
792.4
116.9
116.3
102.3
138.3
0.9
2.1
0.7
0.3
RS-Ibuprofen [24]
1783.0
166.7
0.7
S-Naproxen [25]
S-Naproxen [26]
S-Naproxen [27]
S-Naproxen [6]
3
5
1
5
2304.5
2126.6
1787.5
1871.4
133.2
143.2
167.9
150.4
1.6
2.7
0.4
1.9
Phytosterol [28]
1610.9
206.8
1.7
y
N
ARD =
1
N
2,calc y2,exp
y2,exp
1
100.
468
6x103
4x10
[20]
[21]
[22]
[23]
T ln(E) (K)
T ln(E) (K)
3x10
308 K
313 K
323 K
5x103
4x103
2x10
3x103
1x10
2x103
4
12
16
20
24
12
16
20
24
(mol/dm )
(mol/dm )
6x103
6x10
[6]
[25]
[26]
[27]
5x103
T ln(E) (K)
T ln(E) (K)
5x10
4x103
4x10
323 K
333 K
343 K
3
3x10
3x103
4
12
16
20
24
12
16
20
24
(mol/dm )
(mol/dm )
6x10
[11]
[12]
[16]
T ln(E) (K)
5x10
4x10
3x10
2x10
12
16
20
24
(mol/dm )
1
Fig. 5. T ln E versus solvent density for a) CO2 /Salicylic acid [2023], b) CO2 /RS-Ibuprofen [24], c) CO2 /S-Naproxen [6,2527], d) CO2 /Phytosterol [28], and e) CO2 /S-Naproxen
[11,12,16].
469
Fig. 6. Solubility versus pressure for a) CO2 /Salicylic acid [2123], b) CO2 /RS-Ibuprofen [24], c) CO2 /Phytosterol [28], and d)f) CO2 /S-Naproxen [6]. The three different
correlations used for S-Naproxen are described in the text. Note that the scaling of the axes is different in the four systems because of large differences in solubility.
470
Table 6
Resulting values obtained from tting the four parameters of Eqs. (4) and (5) to the experimental solubility data.
Solute
a (K)
b (cm3 mol1 )
B (K)
Salicylic acid
RS-Ibuprofen
S-Naproxen (1)
S-Naproxen (2)
S-Naproxen (3)
Phytosterol
987.828
1071.39
883.735
892.276
805.23
660.357
34.029
52.4292
81.2094
86.9116
53.4022
106.492
17.7586
31.2614
25.9397
35.8954
17.2568
15.9749
9740.14
14565.9
15442.4
19194.7
11048.6
11847.3
Table 7
Summary of calculation results for the solute solubility in sc-CO2 using various models. It should be noted that the rst two are deviations in the density, the second two in
pressure.
Solute
Salicylic acid
RS-Ibuprofen
S-Naproxen
Phytosterol
9/4
3/1
13/3
3/1
ARD =
1
N
N
y
2,calc y2,exp
y2,exp
0.32.1
0.7
0.42.7
1.7
1044
1633
1433
3777
100.
471
[12] P. Coutsikos, E. Voutsas, K. Magoulas, D.P. Tassios, Prediction of vapour pressures of solid organic compounds with a group-contribution method, Fluid
Phase Equilibria 207 (2003) 263281.
[13] E. Stahl, W. Schilz, E. Schtz, E.A. Willing, Ein Schnellverfahren zur mikroanalytischen Beurteilung des Lsungsvermgens berkritischer Gase, Angewandte
Chemie International Edition 17 (1978) 731738.
[14] S.K. Kumar, J.P. Johnston, Modelling the solubility of solids in supercritical uids
with density as independent variable, Journal of Supercritical Fluids 1 (1988)
1522.
[15] J. Mendez-Santiago, A.S. Teja, The solubility of solids in supercritical uids, Fluid
Phase Equilibria 158160 (1999) 501510.
[16] W.J. Lyman, W.F. Reehl, D.H. Rosenblatt, Handbook of Chemical Property Estimation Methods, American Chemical Society, Washington, DC, 1990.
[17] National
Institute
of
Standards
and
Technology
(NIST):
http://webbook.nist.gov/.
[18] K.D. Ertel, R.A. Healey, C. Koegel, A. Chakrabarti, J.T. Carstensen, Determination of Ibuprofen vapour pressure at temperatures of pharmaceutical interest,
Journal of Pharmaceutical Sciences 79 (6) (1990) 552.
[19] M. Davies, J.I. Jones, The sublimation pressure and heats of sublimation of some
carboxylic acids, Transactions of the Faraday Society 50 (1954) 10421047.
[20] G.S. Gurdial, N.R. Foster, Solubility of o-hydroxybenzoic acid in supercritical carbon dioxide, Industrial & Engineering Chemistry Research 30 (1991)
575580.
[21] E. Reverchon, G. Donsi, D. Gorgoglione, Salicylic acid solubilization in supercritical CO2 and its micronization by RESS, Journal of Supercritical Fluids 6 (1993)
241248.
[22] J. Ke, C. Mao, M. Zhong, B. Han, H. Yan, Solubilities of salicylic acid in supercritical
carbon dioxide with ethanol cosolvent, Journal of Supercritical Fluids 9 (1996)
8287.
[23] M. Trk, R. Lietzow, Formation and stabilization of submicron particles
via rapid expansion processes, Journal of Supercritical Fluids 45 (2008)
346355.
[24] M. Charoenchaitrakool, F. Dehghani, N.R. Foster, H.K. Chan, Micronization by
rapid expansion of supercritical solutions to enhance the dissolution rates
of poorly water-soluble pharmaceuticals, Industrial & Engineering Chemistry
Research 39 (12) (2000) 47944802.
[25] S.S.T. Ting, S.J. MacNaughton, D.L. Tomasko, N.R. Foster, Solubility of Naproxen
in supercritical carbon dioxide with and without cosolvents, Industrial & Engineering Chemistry Research 32 (1993) 14711481.
[26] A. Garmroodi, J. Hassan, Y. Yamini, Solubilities of the drugs benzocaine, metronidazole benzoate, and naproxen in supercritical carbon dioxide, Journal of
Chemical & Engineering Data 49 (2004) 709712.
[27] D. Suleiman, L.A. Estevez, J.C. Pulido, J.E. Garcia, C. Mojica, Solubility of antiinammatory, anti-cancer, and anti-HIV drugs in supercritical carbon dioxide,
Journal of Chemical & Engineering Data 50 (2005) 12341241.
[28] M. Trk, G. Upper, P. Hils, Formation of composite drug-polymer particles by
co-precipitation during the rapid expansion of supercritical uids, Journal of
Supercritical Fluids 39 (2006) 253263.